HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Klaus Hahn Selected Research

Klaus Hahn Research Topics

Disease

3Neoplasm Metastasis (Metastasis)
07/2007 - 05/2003
3Neuroblastoma
10/2003 - 05/2003
2Inflammation (Inflammations)
01/2013 - 11/2004
2Neoplasms (Cancer)
10/2003 - 01/2002
1Atherosclerosis
01/2013
1Thyroid Neoplasms (Thyroid Cancer)
03/2011
1Breast Neoplasms (Breast Cancer)
07/2007
1Pathologic Constriction (Stenosis)
01/2007
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2006
1Penile Neoplasms (Penile Cancer)
09/2005
1Cardiovascular Diseases (Cardiovascular Disease)
07/2005
1Schizophrenia (Dementia Praecox)
06/2005
1Parkinsonian Disorders (Parkinsonism)
01/2005
1Carcinoma (Carcinomatosis)
11/2004
1Ganglioneuroma
10/2003
1Melanoma (Melanoma, Malignant)
05/2003
1Lymphedema (Milroy Disease)
11/2002

Drug/Important Bio-Agent (IBA)

33-Iodobenzylguanidine (Iobenguane)IBA
10/2003 - 05/2003
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
01/2013
1Apolipoproteins E (ApoE)IBA
01/2013
1Proteins (Proteins, Gene)FDA Link
01/2013
1ThyroglobulinFDA Link
03/2011
1Tumor Biomarkers (Tumor Markers)IBA
07/2007
1Phenobarbital (Luminal)FDA Link
01/2007
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
09/2006
1Methylphenidate (Ritalin)FDA LinkGeneric
09/2006
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
09/2005
1DobutamineFDA LinkGeneric
07/2005
1Amisulpride (Solian)IBA
06/2005
13- iodo- 2- hydroxy- 6- methoxy- N- ((1- ethyl- 2- pyrrolidinyl)methyl)benzamideIBA
01/2005
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2005
1RadiopharmaceuticalsIBA
11/2004
1Iodine-123IBA
10/2003
1IodineIBA
06/2003
1rhenium sulfide (ReS2)IBA
05/2003
1Pharmaceutical PreparationsIBA
01/2002

Therapy/Procedure

2Therapeutics
03/2011 - 09/2006
1Aftercare (After-Treatment)
09/2006
1Heart Transplantation (Grafting, Heart)
07/2005
1Gamma Cameras (Gamma Camera)
11/2004
1Drug Therapy (Chemotherapy)
10/2003
1Transplantation
11/2002